Malignant Pituitary Tumours

Pituitary

Volumn 1, Issue 1, 1998, Pages 69-81

  Kaltsas, G A ^a   Grossman, A B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Malignancy; Metastases; Pituitary tumours

Indexed keywords

CORTICOTROPIN;

ADENOMA; BRAIN TUMOR; CANCER INVASION; CARCINOMA; HUMAN; HYPOPHYSIS TUMOR; METASTASIS; MULTIMODALITY CANCER THERAPY; ONCOGENE; PATHOLOGY; REVIEW; SECRETION;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; BRAIN NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; ONCOGENES; PITUITARY NEOPLASMS;

EID: 0032034467     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009975009924     Document Type: Article

References (91)

1. Frost AE, Tenner S, Tenner M, Rollhauser C, Tabbara SO. ACTH-producing pituitary carcinoma presenting as cauda equina syndrome. Arch Pathol Lab Med 1995;119:93-96.
2. Selman WR, Laws ER, Scheithauer BW, Carpenter SM. The occurence of durai invasion in pituitary adenomas. J Neurosurg 1986;64:402-407.
3. Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of invasive pituitary tumours with special reference to functional classification. J Neurosurg 1986;65:733-744.
4. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: A clinicopathological study of 15 cases. Cancer 1997;79:804-812.
5. Doniach I. Pituitary carcinoma. Clin Endocrinol 1992;37: 194-195. Oxford.
6. Popovic EA, Vattuone JR, Siu KA, Busmanis I, Pullar MJ, Bowling J. Malignant prolactinomas. Neurosurgery 1991; 29:127-130.
7. Doniach I. Pituitary carcinoma. In: Sheures R, Jenkins P, Hnou JA (eds.). Clinical Endocrine Oncology. Oxford: Blackwell Science Ltd., 1997:225-227.
8. Mountcastle RB, Roof BS, Mayfield RK, et al. Case report: Pituitary adenocarcinoma in an acromegalic patient: Response to bromocriptine and pituitary testing: A review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 1989;298:109-118.
9. Price PA. Cytotoxic chemotherapy for aggressive pituitary tumours. In: Grossman AB (ed.). Clinical Endocrinology. Oxford: Blackwell Sci Pub., 1992:235-237.
10. Kuvoki M, Tanaka R, Yokoyama M, Shimbo Y, Ikuta F. Subarachnoid dissemination of a pituitary adenoma. Surg Neurol 1987;28:71-76.
11. Garrao AF, Sobrincho G, Oliveira P, et al. ACTH-producing carcinoma of the pituitary with haematogenic metastases. Eur J Endocr 1997;137:176-180.
12. Nudleman KL, Choi B, Kusske JA. Primary pituitary carcinoma: A clinical pathological study. Neurosurgery 1985; 16:90-95.
13. Wilson DF. Pituitary carcinoma occuring as middle ear tumour. Otolaryngol Head Neck Surg 1982;90:665-666.
14. Herman V, Fagin J, Gonsky R, Kovacs KT, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71:1427-1433.
15. Farrell WE, Talbot JA, Bicknell EJ, Simpson D, Clayton RN. Genomic sequence analysis of a key residue (Arg 183) in human Gaq in invasive non-functional pituitary adenomas. Clin Endocrinol 1997;47:241-244.
16. Luzi P, Miracco C, Lio R, et al. Endocrine inactive pituitary carcinoma metastasizing to cervical lymph nodes: A case report. Hum Pathol 1987;18:90-92.
17. Taylor WA, Uttley D, Wilkins PR. Multiple durai metastases from a pituitary adenoma. J Neurosurg 1994;81:624-626.
18. Thapar K, Yamada Y, Scheithauer B, Kovacks K, Yamada S, Stefaneanu L. Assessment of mitotic activity in pituitary adenomas and carcinomas. Endocr Pathol 1996;7:215-221.
19. Bates AS, Farrell WE, Bicknell EJ, et al. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 1997;82:818-824.
20. Walker JD, Grossman AB, Anderson JV, et al. Malignant prolactinoma with extracanial metastases: a report of three cases. Clin Endocrinol 1993;38:411-419.
21. Hurel SJ, Harris PE, McNicol AM, Foster S, Kelly WF, Baylis PH. Metastatic prolactinoma: Effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of protooncogene expression. J Clin Endocrinol Metab 1997;82:2962-2965.
22. Assai A, Matsutani M, Nobuaki F, Tarakura K. Malignant growth hormone-secreting pituitary adenoma with haematogenous dural metastasis: Case report. Neurosurgery 1988;22:1091-1094.
23. Muhr C, Bergstom M, Lundberg PO, et al. Malignant prolactinoma with multiple intracranial metastases studied with positron emmision tomography. Neurosurgery 1988;22: 374-379.
24. Yamashita S, Izumi M, Nagataki S. Acromegaly and pituitary carcinoma. Ann Intern Med 1992;117:1057.
25. Gasser RW, Finkenstedt G, Skrabal F, et al. Multiple intracranial metastases from a prolactin secreting pituitary tumour. Clin Endocrinol 1985;22:17-27.
26. Landolt AM. Ultrastructure of human sella tumours. Acta Neurochir (Suppl) 1975;22:94.
27. Martin NA, Hales M, Wilson CB. Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 1981;55:615-619.
28. Hashimoto N, Handa H, Nishi S. Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumour. J Neurosurg 1986;64:140-144.
29. Hardy J. Transphenoidal microsurgical treatment of pituitary tumours. Recent advances in the diagnosis and treatment of pituitary tumours. New York: Raven Press, 1979: 375-378.
30. Stewart PM, Carey MP, Graham CT, Wright AD, London R. Growth hormone secreting pituitary carcinoma: A case report and literature review. Clin Endocrinol 1992;37:189-195.
31. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs KT. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156-158.
32. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population. Ann Intern Med 1994;120:817-820.
33. Faglia G. Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol 1993;129:1-5.
34. Shimon I, Melmed S. Pituitary tumour pathogenesis. J Clin Endocrinol Metab 1997;82:1675-1681.
35. Boggild MD, Jenkinson S, Pistorelo M, et al. Molecular genetic studies of sporadic pituitary tumours. J Clin Endocrinol Metab 1994;78:387-392.
36. Golland R, Kosty M, Cheney C, Copeland B, Bordin G. Prolactin secreting pituitary carcinoma with implants in the cheek pouch and metastases to the ovaries. Cancer 1995;76:1814-1820.
37. Atienza DM, Vigersky RJ, Lack E, et al. Prolactin producing pituitary carcinoma with pulmonary metastases. Cancer 1991;68:1605-1610.
38. Cohen H, Dible JH. Pituitary basophilism associated with a basophil carcinoma of the anterior lobe of the pituitary gland. Brain 1937;59:395-407.
39. Fitzgibbons PL, Appley AJ, Turner RR, et al. Flow cytometric analysis of pituitary tumours. Correlation of nuclear antigen p105 and DNA content with clinical behaviour. Cancer 1988;62:1556-1560.
40. Saunter D, Saeger W Invasiveness of pituitary adenomas. Pathol Res Pract 1991;187:632-636.
41. Ikeda H, Yoshimoto Y. The relationship between c-myc protein expression, the bromodeoxyuridine labelling index and the biological behaviour of pituitary adenomas. Acta Neuropathol 1992;83:361-364.
42. Bravo R, Frank R, Blundell PA, McDonald-Bravo H. Cyclin PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-517.
43. Cusimano MD, Ohori P, Martinez JA, Jungreis C, Wright D. Pituitary carcinoma. Skull Base Surg 1994;4:46-51.
44. Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P, Harris PE. Gsa and Gi2a mutations in clinically non-functioning pituitary tumours. Clin Endocrinol 1994; 41:815-820.
45. Karga HJ, Alexander JM, Hedley E.T, Klibansky A, Jameson JL. ras mutations in human pituitary tumours. J Clin Endocrinol Metab 1992;74:914-919.
46. Cai WY, Alexander JM, Hedley-Whyte ET, et al. Ras mutations in human probotinomas and pitutary carcinomas. J Clin Endocrinol 1994;78:89-93.
47. Takino H, Herman V, Weiss M, Melmed M. Purine binding factor (nm23) gene expression in pituitary tumours:marker of adenoma invasiveness. J Clin Endocrinol Metab 1995; 80:1733-1738.
48. Pei L, Melmed S, Scheithauer B, Kovacks K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumours:evidence for a chromosome 12 tumour suppressor gene other than RB. Cancer Res 1995;55: 1613-1616.
49. Woloschak M, Roberts JL, Post KD. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumours. Cancer 1994;74:693-696.
50. Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastome gene in human pituitary tumours. J Clin Endocrinol Metab 1993;77:644-646.
51. Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell 1990;61:759-767.
52. Dahia PLM, Aguiar RCT, Honegger J, et al. Mutation and expression analysis of the P27/kip1 gene in corticotrophin-secreting tumours. Oncogene 1997(1998)16:69-76.
53. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY. Heterozygous Rb-1 delta/+mice predisposed to tumours of the pituitary gland with a nearly complete penetrance. Oncogene 1994;9:1021-1027.
54. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85:733-744.
55. Peterson T, McFarlane IA, McKenzie JM, Shaw MD. Prolactin secreting pituitary carcinoma. J Neurol Neurosurg Psychiatry 1992;55:1205-1206.
56. Cartwright DM, Miller TR, Nasr AJ. Fine needla aspiration biopsy of pituitary carcinoma with cervical lymph node metastases: A report of two cases and review of the literature. Diagn Cytopathol 1994;11:68-73.
57. McCormick PC, Post KD, Kandji AD, Hayes AP. Malignant tumours of the pituitary gland. Arch Neurol 1992;49: 555-558.
58. Chiang MF, Brock M, Patt S. Pituitary metastasis. Neurochirurgica 1990;33:127-131.
59. Landgraf R, Rieder G, Schmiedek P, Clados D, Bise K, Werder K. Hormoneactive intradural spinal metastasis from a prolactinoma-a case report. Klin Neurosurg Psychol 1985; 63:379-384.
60. Saeger W, Bosse U, Pfinst E, et al. Prolacting-secreting pituitary carcinoma. Case report of a very rare metastasizing tumour. Pathologe 1995;16:354-358.
61. Bates AS, Buckley N, Boggild EJ, et al. Clinical and genetic changes in a case of a Cushing's syndrome. Clin Endocrinol 1995;42:663-670.
62. Lormeau B, Miossec P, Sibony M, Valenci P, Attali J. Adrenocorticotropin-producing pituitary carcinoma with liver metastasis. J Endocrinol Invest 1997;20:230-236.
63. Myles ST, Johns RD, Curry B. Carcinoma of the pitutary gland with metastases to the bone. Can J Neurol Sci 1984;11:310-317.
64. Dayan C, Guilding T, Hearing S, et al. Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases. Clin Endocrinol 1996;44:597-602.
65. Greenman Y, Woolf P, Coniglio J, et al. Remission of acromegaly caused by pituitary carcinoma after surgical excision og growth-hormone secreting metastasis detected by 111-Indium pentetreotide scan. J Clin Endocrinol Metab 1997;81:1628-1633.
66. Beauchesne P, Trouillas J, Brral F, Brunon J. Gonadotropic pituitary carcinoma: Case report. Neurosurgery 1995;37: 810-816.
67. Mixson AJ, Friedman TC, Katz DA, et al. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 1993;76:529-533.
68. Jamjoom A, Moss T, Coakham H, Jamjoom AZ, Antony P. Cervical lymph node metastases from a pituitary carcinoma. Br J Neurosurg 1994;8:87-92.
69. Kaizer FE, Orth DN, Mukai K, Oppenhaimer JH. A pituitary parasellar tumour with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides. J Clin Endocrinol Metab 1983;57:649-653.
70. Gabrilove JL, Anderson PJ, Halmi NS. pituitary proopiomelanocortin-cell carcinoma occuring in conjunction with glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome. Clin Endocrinol 1986;25: 117-126.
71. Moberg A. A case of pituitary chromophobe adenoma with metastases in the heart. Acta Pathol Microbiol Scand 1959; 45:243-249.
72. Sheldon WH, Golden A, Bondy PK. Cushing's syndrome produced by pituitary baseophil carcinoma with hepatic metastases. Am J Med 1954;17:134-142.
73. Queiroz LS, Facure NO, Facure JJ, Modesto NP, deFaria JL. Pituitary carcinoma with liver metastasis and Cushing's syndrome. Arch Pathol 1975;99:32-35.
74. Nawata H, Higushi K, Ikuyama S, et al. Corticotropin-releasing hormone and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease. J Clin Endocrinol Metab 1990;71:1068-1073.
75. Scheithauer BW, Randall RV, Lavos ERJ, Kovacs KT, Horvath E, Whitaker MD. Prolactin cell crcinoma of the pituitary. Cancer 1985;55:598-604.
76. Tonner D, Belding P, Moore SA, Schlechte JA. Intracranial dissemination of an ACTH secreting pituitary neoplasm-A case report and review of the literature. J Endocrinol Invest 1992;15:387-391.
77. Cohen DL, Diengdoh JV, Thomas DGT, Himsworth RL. An intracranial metastasis from a PRL secreting pituitary tumour. Clin Endocrinol 1983;18:259-264.
78. Figarella-Branger D, Trouillas J, Morange I. Prolactin pituitary carcinoma with multiple systemic metastasis. Endocr Path 1992;3(Suppl 1):S11-S12.
79. Hoi Sang U, Johnson C. Metastatic prolactin secreting pituitary adenoma. Hum Pathol 1984;15:94-96.
80. Epstein A, Epstein BS, Molho L, Zimmerman HM. Carcinoma of the pituitary gland with metastases to the spinal cord and roots of the cauda equina. J Neurosurg 1964;21:846-853.
81. Gesundheit N, Petrick PA, Nissim M. Thyrotropin secreting pituitary adenomas: Clinical and biochemical heterogenisity. Ann Intern Med 1989;111:827-835.
82. Hsu DW, Hakim F, Biller BMK, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753-761.
83. Reubi JC, Mauer R, von Werder K, Torhorst J, Klinj JG, Lamberts SW Somatostatin receptors in human endocrine tumours. Cancer Resear 1987;47:551-558.
84. Papotti M, Limone P, Riva C, Gatti G, Bussolati G. Malignant evolution of an ACTH-producing pituitary tumour treated with intrasellar implantation of 90Y. Appl Pathol 1984;2:10-21.
85. Shrieve DC, Tarbell NJ, Alexander E3, et al. Stereotactic radiotherapy: A technique for dose optimization and escalation for intracranial tumors. Acta Neurochir Suppl 1994;62: 118-123.
86. Lippman SM, Mendelsohn G, Trump D, Wells JS, Baylin S. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma. J Clin Endocrinol Metab 1982;54:233-240.
87. Yin KJ. Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei in the rat. Anat Rec 1995;241:579-584.
88. Davis JRE, Sheppard MC, Heath DA. Giant invasive prolactinoma: A case report and review of nine further cases. Quar J Med 1990;74:259-264.
89. Murphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. Giant invasive prolactinomas. Am J Med 1987;83:995-1002.
90. Vaughan NJA, Laroche CM, Goodman I, Davies MJ, Jenkins JS. Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol 1985;22:147-153.
91. Kasperlik-Zaluska AA, Wislawski J, Kaniewska J, Zborzil J, Frankiewicz E, Zgliczynski S. Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol 1987;116:347-349.